Some people still do not understand the current ISCO situation !!!
ISCO currently has total of 600 million authorized shares including 300 million recently authorized. Out of all that 600 million shares, only apprx. 157 million shares had been sold and only 400,000 to 700,000 shares are being traded on daily base. So, apprx. 443 million shares are in the possession of ISCO now, NOT BEING SOLD. ISCO is reserving these shares for their future fund needed. HOWEVER, I am very much sure that they don't want to start selling the shares at $0.15 while they know that their stock price should worth a lot more than $0.15. One of the things mentioned in Q1 Earning Report Conference Call was actually about the recent low stock price. They blamed the overall bio-tech stock downtrend which I totally do not agree with. $0.15 per share now has caused by their serious negligence in promoting and marketing. I believe ISCO is finally realizing what they were lacking of, especially with newly authorized shares of 300 million and left over of 143 million shares that they are holding. I am very feasibly hoping that ISCO will start doing what other companies do to promote and market their companies very soon in order to raise up the stock price. HAVING SAID ALL THESE, the dilution by additionally authorized shares are NOT the problem with ISCO right now. Again, IT IS the lack of "promotion and marketing" that can very simply be done by ISCO once they realize how important for them to do it for themselves as well. 443 million shares they are holding? If they sell them all at $0.15, it will be only about 66 million dollars. Current management may not know how to operate business, but I don't think they are crazy enough to sell the shares at $0.15. Soon enough, the whole thing will turn and the stock price will start escalating to where it should have been.
